Načítá se...
Albuminuria is Not an Appropriate Therapeutic Target in Patients with CKD: The Con View
Albuminuria is a risk factor for progression of kidney disease. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers slow the progression to ESRD, an effect that is correlated with reduction in albuminuria. This has led to the hypothesis that albuminuria should be a target for t...
Uloženo v:
| Vydáno v: | Clin J Am Soc Nephrol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Nephrology
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4455218/ https://ncbi.nlm.nih.gov/pubmed/25887070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.10681014 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|